Trial data suggest that management of vitamin D deficiency should be considered in patients with frequent attacks of benign paroxysmal positional vertigo.
Patricia K. Coyle, MD, reviews the mechanism of action of ocrelizumab in multiple sclerosis and discusses the results of the phase 3 ORATORIO trial.

SAP Partner Banner